Plant Biotechnology Market To Reach USD 276.9 Billion By 2032 - DataHorizzon Research
April 06, 2024 10:00 ET
|
DataHorizzon Research
Fort Collins, Colorado, April 06, 2024 (GLOBE NEWSWIRE) -- The Plant Biotechnology Market was valued at USD 105.1 Billion in 2023 and is anticipated to grow CAGR at 11.4% and reach USD 276.9 Billion...
Key Players and Market Dynamics Explored in Latest Plant Biotechnology Equipment Report
August 30, 2023 07:48 ET
|
Research and Markets
Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "Plant Biotechnology Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The "Global Strategic...
22nd Century Group Reports Business Highlights and Financial Results for the Second Quarter 2021
August 05, 2021 06:00 ET
|
22nd Century Group, Inc
Initiated International Launch Process For VLN®, First Sales Planned by First Quarter 2022First Revenue From Hemp/Cannabis Franchise to Commence in Second Half of 2021Third Plant-Based Franchise to be...
22nd Century Advances Initiatives to Strengthen and Maximize Revenue Opportunities in Hemp/Cannabis Franchise
June 07, 2021 10:42 ET
|
22nd Century Group, Inc
Close Partnership With Aurora Cannabis Inc. to Enforce Shared Global Biosynthesis IP Rights Against Infringement and Actively Explore Commercial Development Opportunities; Monetization of Key Patented...
22nd Century Announces $40 Million Common Stock Registered Direct Offering
June 07, 2021 09:25 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., June 07, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine...
22nd Century Group Receives Additional $3.7 Million from Cash Exercise of Outstanding Warrants
March 12, 2021 10:00 ET
|
22nd Century Group, Inc
WILLIAMSVILLE, N.Y., March 12, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low...
22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2020
March 11, 2021 07:00 ET
|
22nd Century Group, Inc
Key Business and Financial Highlights 22nd Century has a tremendous global commercial opportunity in the more than $800 billion markets across the tobacco and hemp/cannabis industry.Securing Modified...
22nd Century Group Receives $8.1 Million from Cash Exercise of Outstanding Warrants
March 04, 2021 09:15 ET
|
22nd Century Group, Inc
WILLIAMSVILLE, N.Y., March 04, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low...